NCT03379701

Brief Summary

Professor Hossam Haick from the Technion, developed an electronic nose for diagnosis of diseases via breath samples. Biomarkers from nose and sinuses and upper respiratory tract can be detected by "electronic nose". Identification of biomarkers from nose and sinuses and upper respiratory tract can differentiate between the subtypes of CRS (Chronic rhinosinusitis) and may serve as markers for disease (vs controls), of disease activity (predicting aggressive disease course, predicting Malignant vs Benign nasal "polyps", as inverted papillpma or carcinoma; predicting response to therapy (Steroid , Antibiotics, Nasal wash, Surgery).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
71

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2014

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 28, 2014

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 27, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 27, 2016

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

November 22, 2017

Completed
28 days until next milestone

First Posted

Study publicly available on registry

December 20, 2017

Completed
Last Updated

December 20, 2017

Status Verified

December 1, 2017

Enrollment Period

2 years

First QC Date

November 22, 2017

Last Update Submit

December 19, 2017

Conditions

Keywords

chronic rhinosinusitis, nasal polyposis

Outcome Measures

Primary Outcomes (2)

  • discrimination between healthy and CRS subtypes based on SNOT 22 questionnaire results

    SNOT 22 score (score 0-110)

    change in score from recruitment and every six month until 3 years after recruitment.

  • Successful discrimination between healthy and CRS subtypes based on sensor response (electrical resistance measurements)

    Electrical resistance-Disease diagnosis based on breath analysis data classification using an artificial olfactory system (AKA, Electronic nose)

    Change of electrical resistance from recruitment and every six month until 3 years after recruitment.

Study Arms (7)

CRSwPolyps with no Eosonophilia

CRS patients with nasal polyposis, and no eosonophilia.

CRSwPolyps with Eosonopholia

CRS patients with nasal polyposis and eosonophilia.

CRS without Polyps

Patients with chronic rhinosinusitis and no nasalpolyposis.

PCD

Patients with Primrary ciliary dyskinesia .

AFRS

Patients with allergic fungal rhinosinusitis.

allergic rhinitis

Patients with allergic rhinitis

Control

Healthy subjects.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

CRS patients will be recruited through the Rhinologic clinic at the Hillel Yaffe Medical Center, after signing an informed consent. Healthy individuals that meet the inclusion/ exclusion criterions will be recruited from among the patient's escorts to the clinic or patients coming for other surgeries (unrelated spouse or acquaintance after signing an informed consent.

You may qualify if:

  • CRS patients that presented in the Rhinologic clinic at the Hillel Yaffe Medical Center. CRS patients that never had FESS - endoscopic sinus surgery.
  • Willing and able to give inform consent
  • Control subjects:
  • Age and gender match control individuals that do not have CRS or any other condition that is defined as nasal disease. These individuals will be recruited as "Healthy Population Reference" group.
  • Willing and able to give informed consent

You may not qualify if:

  • Patients age 18 or less, pregnant women
  • Presence of HIV, hepatitis or any other potentially severe and infectious disease. Patient that had sinus surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

An overall of 2-4 liter breath samples will be collected in inert Mylar bags and immediately transferred to sorbent tubes.

MeSH Terms

Conditions

Nasal Polyps

Condition Hierarchy (Ancestors)

Nose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 22, 2017

First Posted

December 20, 2017

Study Start

September 28, 2014

Primary Completion

September 27, 2016

Study Completion

September 27, 2016

Last Updated

December 20, 2017

Record last verified: 2017-12